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http://dx.doi.org/10.1016/j.fjs.2013.Summary Purpose: To describe the epidemiological profiles and the amputation and mortal-
ity rates of diabetic patients in Taiwan with critical limb ischemia.
Materials and methods: Data were collected from the Longitudinal Health Insurance Database
2000 (LHID2000), a database composed of one million randomly selected beneficiaries in
Taiwan. To measure major amputation and mortality, diabetic patients with critical limb
ischemia (CLI) were identified by specific ICD-9-CM diagnostic, procedure, and order codes.
The patients were traced until the end of 2009. Cox proportional hazard regressions were used
to determine the crude and adjusted hazard ratios for the risk factors for amputation and mor-
tality during the follow-up period.
Results: We identified 6418 diabetic patientswith CLI from the LHID database during 1997e2006.
Of these patients, 256 (3.99%) patients underwent surgical revascularization and 6418 (96.01%)
patients receivedconservative treatment only. The revascularization cohort hadmorecomorbid-
ities than the surgical group (e.g., cardiovascular, 13.28% vs. 8.62%, respectively, pZ 0.0099;
renal, 23.05% vs. 5.34%, respectively, p < 0.0001). The amputation and mortality rates for dia-
betic CLI patients in Taiwan were 5.75% and 18.62%, respectively. Male gender, an age of greaterof Anesthesiology, Chi Mei Medical Center, 901 Zhonghua Road, Yongkang District, Tainan 71004,
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80 K.-C. Liao et al.than 50 years old, and cardiovascular and renal comorbidities were identified as risk factors for
amputation. The risk factors for mortality also included old age (i.e., >50 years), male gender,
and comorbid cardiovascular, renal, neurological, and pulmonary diseases.
Conclusion: Diabetic patients who needed surgical revascularization or who needed conserva-
tive treatment for CLI had different comorbid profiles. The common risk factors for amputation
andmortality in diabetic CLI patients includemale gender, age of>50 years, and concurrent car-
diovascular and renal diseases.
Copyright ª 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Diabetes mellitus (DM) reportedly gives a 2e4-fold increased
risk of critical limb ischemia (CLI),1,2 and 12e20% of CLI cases
are secondary to diabetes. 2,3 Diabetes mellitus may impair
peripheral circulation by elevating vasomotor tone and
attenuating sensitivity to shear stress and the response to
vasodilatory stimuli, thereby reducing the recruitment and
dilatation of collateral arteries.4 Endothelial progenitor cell
(EPC) function is also attenuated in diabetes and thus reduces
arteriogenesis in peripheral circulation.4 The risk of developing
CLI is moreover proportional to the severity and duration of
diabetes.5 Diabetic patients with CLI are 7e15-fold more likely
to undergo a major amputation, compared to nondiabetics
with CLI.6 Recent reports demonstrate that the prevalence of
CLI in diabetic patients is increasing in Taiwan7e9 and is
generating a very high total national workload.9
Established treatment options for patientswith severe leg
ischemia include conservative treatment with thrombolytic
agents, percutaneous transluminal angioplasty (PTA), or
arterial reconstruction. However, the optimal methods of
treatment remain controversial. The outcome of CLI in
peoplewith diabetes is inferior to its outcome in nondiabetic
patients.10 Numerous studies demonstrate poor outcomes of
revascularization in diabetic patients with CLI.11e14 A recent
report from a multicenter randomized control trial shows
that bypass surgery and angioplasty interventions have
similar outcomes in regard to amputation-free survival.15
Some studies, however, suggest that DM patients with CLI
may benefit from aggressive revascularization.16,17
However, little is known about the natural history of
diabetic patients with CLI in non-Caucasian racial or ethnic
groups, particularly in Chinese people. A good under-
standing of the epidemiology of the disease may improve its
detection and treatment in different races. This is relevant
for reducing disparities in health status. Therefore, we
have decideddby using a nationwide population-based
databasedto describe the specific epidemiologic profiles
and to evaluate major limb amputation and mortality rates
of diabetic patients in Taiwan with CLI who need revascu-
larization or conservative treatment.
2. Materials and methods
2.1. Database
On March 1, 1995, Taiwan launched a single-payer National
Health Insurance (NHI) program. The NHI offers comprehensive medical care coverage to all Taiwanese residents. As of
2007, more than 98% (22.60 million) of Taiwan’s 22.96 million
legal residents (citizens and noncitizens) were enrolled in this
program. The NHI Research Database (NHIRD) provides
encrypted patient identification numbers, gender, date of
birth, dates of admission and discharge, the ICD-9-CM (Inter-
national Classification of Diseases, Ninth Revision, Clinical
Modification) codes of diagnoses and procedures, details of
prescriptions, and costs covered and paid for by the NHI. The
Longitudinal Health Insurance Database 2000 (LHID2000), a
subdataset of the NHIRD, contains all claim data (from 1996 to
2009) of onemillionbeneficiarieswhowere randomly selected
from the system in 2000. Therewere no significant differences
in age, gender, or average insured payroll-related premiums
between the sample group and all enrollees. The National
Health Research Institutes approved the present study.
2.2. Selection of patients and variables
Patients were included as having diabetes mellitus if they
had at least one hospital admission with a diagnostic code
of diabetes (ICD-9 codes 250 or A-code 181) or three or
more outpatient visits with a diabetes diagnostic code
within 365 calendar days. This rule of enrollment has been
adapted by many previous studies in the medical literature
18e20 and the accuracy has been validated.21 Diabetic pa-
tients who also had one of the six following codes were
enrolled as our study cohort: (1) ICD-9 code 440.22
(atherosclerosis of the extremities with rest pain); (2) ICD-9
code 440.23 (atherosclerosis of the extremities with ul-
ceration); (3) ICD-9 code 440.24 (atherosclerosis of the
extremities with gangrene); (4) ICD-9 code 440.4 (chronic
total occlusion of one or more arteries of the extremities);
(5) ICD-9 code 444.2 (arterial embolism or thrombosis of the
extremities); or (6) ICD-9 code 250.7 (diabetes with pe-
ripheral circulatory disorders) and either ICD-9 code 785.4
(gangrene) or ICD-9 code 443.81 (peripheral angiopathy).
We thus identified from the LHID database 6418 incident
patients who had been treated between January 1, 1997
and December 31, 2006.
We also used order code 69004 (vascular endarterec-
tomy), code 69032 (vessel bypass grafting), and code 33074
(angioplasty) to subclassify patients who received surgical
revascularization interventions. Those diabetic CLI patients
who did not receive the aforementioned procedures during
the observation period were classified in the conservative
treatment subgroup.
Sampled patients were followed until amputation,
mortality, or the end of 2009, whichever came first. Each
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procedure codes 84.12e84.19 to identify patients who un-
derwent amputation. The amputations were subdivided
into two classes: (1) above-knee (AK) amputation, which
includes disarticulation of the knee and abdominopelvic
amputation (codes 84.17e84.19) and (2) below-knee (BK)
amputation, which includes disarticulation of the ankle
(codes 84.13e84.16) and midfoot or toe amputations
(codes 84.11e84.12). These procedures were verified by
specific order codes. Traumatic amputations were not
included (E878.5). Deaths were identified by using the “in-
hospital death” coded at discharge. However, it is a custom
of many Taiwanese to die at home; therefore, the in-
hospital death code would underestimate the true hospital
mortality. We thus assigned, on presumption, in-hospital
deaths to patients who were attrited from the NHI within 3
days of hospital discharge because of universal coverage of
the NHI and unlikely emigration shortly after discharge with
severe disease.
Systemic diseasesdincluding respiratory, cardiac, renal,
cerebrovascular, and gastrointestinal comorbiditiesdwere
recorded by their ICD-9-CM codes. SAS for Windows 9.3
software (SAS Institute, Inc., Cary, NC, USA) was used for
this study. Descriptive statistical analyses using c2 tests or
Fisher’s exact test were performed to compare the char-
acteristics of the two cohorts by demographic characteris-
tics and by selected comorbid disorders. Stratified Cox’s
proportional regression was used to compute the hazard
ratio for amputation or mortality during the follow-up
period. A p value less than 0.05 was statistically significant.3. Results
From the LHID2000 database, we identified 6418 diabetic
patients with CLI; 256 (3.99%) patients underwent surgical
revascularization and 6157 (96.01%) patients received only
conservative treatment. Table 1 summarizes the patient
demographic data and comorbidities. There was no signifi-
cant gender discrepancy in CLI in diabetic patients (49.45%
vs. 50.55% for males and females, respectively;
p Z 0.8674). However, significantly more male patients
received revascularization treatments (59.38% vs. 40.63%
for males and females, respectively; p Z 0.0039).
Approximately 62.39% of diabetic patients with CLI were
more than 60 years old. For patients with CLI who needed
surgical revascularization, 67.19% were >60 years. The
revascularization cohort also had significantly more car-
diovascular comorbidities (13.28% vs. 8.62% for the revas-
cularization cohort and conservative cohort, respectively;
p Z 0.0099) and renal comorbidities (23.05% vs. 5.34%, for
revascularization cohort and conservative cohort, respec-
tively; p < 0.0001). Patients with a low economic status had
a greater chance of needing surgical intervention. In addi-
tion, 64.84% of the revascularization surgeries were per-
formed at medical centers and only 35.16% of the surgeries
were performed at local hospitals (p < 0.0001). The
elapsed time from the diagnosis of CLI to surgical inter-
vention was 38.12  34.1 months.
Table 2 shows that the overall amputation rate was
5.75% (i.e., 369 of 6418 diabetic CLI patients). Compared to
patients who did not undergo amputation, 72.36% ofpatients who had an amputation were mostly >60 years
old, male (59.89%), and had more concurrent cardiovascu-
lar diseases (25.75% vs. 7.77%, amputation group and no
amputation group, respectively; p < 0.0001); neurological
diseases (19.78% vs. 13.66% for the amputation group and
no amputation group, respectively; p Z 0.001); and renal
diseases (15.99% vs. 5.44%, amputation and no amputation,
respectively; p < 0.0001).
Table 3 presents the distribution of amputation in pa-
tients receiving conservative and revascularization treat-
ment. The 256 revascularization patients underwent a
total of 346 procedures during the study period. The most
frequently performed surgical intervention was vessel
bypass grafting [51.56% (132/256 patients); p < 0.001],
followed by endarterectomy (19.92%) and angioplasty
(18.36%). Approximately 10% of patients had more than
two types of surgical interventions. The patients who
received bypass grafts and combination intervention were
younger than patients receiving angioplasty and endarter-
ectomy [p < 0.001, based on analysis of variance (ANOVA)
test]. The crude total amputation rate was 5.32% (328 of
6162 patients) for the conservative group and 16.08% (41 of
256 patients) for the revascularization group. Compared to
patients who underwent in-between revascularizations,
patients who underwent combined surgery and endarter-
ectomy had a higher total amputation rate than patients
who underwent angioplasty and bypass grafting [38.46%
(combined), 21.57% (endarterectomy), 12.77% (angio-
plasty), and 10.61% (bypass grafting), p Z 0.0027, based on
the Chi-square test].
Table 4 shows the Cox proportional hazard regressions
of the crude and adjusted hazard ratios for amputation
during the follow-up period by the cohorts of the total
sample. Age ranges of 50e59 years, 60e69 years, and >70
years had an increased amputation risk of 1.683-fold [95%
confidence interval (CI), 1.107e2.559], 1.962-fold (95% CI,
1.328e2.900), and 2.142-fold (95% CI, 1.462e3.137),
respectively, in comparison to the amputation risk in
patients < 50 years. Gender was also a risk factor for
amputation. The adjusted hazard ratio was 0.711 (95% CI,
0.574e0.881) for females. A comorbid cardiovascular dis-
order posed a 3.472-fold hazard ratio (95% CI, 2.691e4.480)
for amputation. Concurrent renal disorders moreover pre-
sented a 2.801 times higher risk for amputation (95% CI,
2.804e3.764).
During the follow-up period, the cumulated mortality
rate for diabetic CLI patients in Taiwan was 18.62%. As
Table 5 shows, 59.25% of patients who were >70 years had
the highest mortality. A gender discrepancy existed be-
tween the two sexes in survival and mortality rates. In re-
gard to patient mortality, 54.64% of the patients were male
and 45.36% of the patients were female (p Z 0.0017). Pa-
tients who died had more concurrent cardiovascular,
neurological, pulmonary, renal, hepatic, and gastrointes-
tinal diseases, compared to patients who survived.
After adjusting for age, gender, and comorbid diseases
as confounding factors, higher hazard ratios were deter-
mined for mortality, old age (50e59 years, 60e69 years,
and >70 years), male gender, and all selected comorbid-
ities (except rheumatologic disease; Table 6). For patients
>70 years, the hazard ratio was 4.501 (95% CI, 3.553-5.701)
higher than for patients < 50 years. A comorbid renal
Table 1 Demographic characteristics and comorbid medical disorders of diabetic patients with critical limb ischemia,
stratified by treatment modality, in Taiwan from 1997 to 2006.
CharPatients’ characteristicsa Total Conservative Revascularization p*
6418 (100) 6162 (96.01) 256 (3.99)
Age (y) 0.2048
<50 1123 (17.50) 1090 (17.69) 33 (12.89)
50e59 1291 (20.12) 1240 (20.12) 51 (19.92)
60e69 1730 (26.96) 1652 (26.81) 78 (30.47)
70 2274 (35.43) 2180 (35.38) 94 (36.72)
Gender 0.0039
Male 3174 (49.45) 3070 (49.82) 152 (59.38)
Female 3244 (50.55) 3092 (50.18) 104 (40.63)
Comorbid disorders
Cardiovascular 565 (8.80) 531 (8.62) 34 (13.28) 0.0099
Neurologic 899 (14.01) 862 (13.99) 37 (14.45) 0.8339
Pulmonary 707 (11.11) 678 (11.00) 29 (11.33) 0.8706
Renal 388 (5.34) 329 (5.34) 59 (23.05) <0.0001
Hepatic and gastrointestinal 1201 (18.71) 1163 (18.87) 38 (14.84) 0.1052
Rheumatologic 52 (0.81) 49 (0.80) 3 (1.17) 0.5101
Monthly income 0.0170
NTD  15,840 3846 (59.93) 3673 (59.61) 173 (67.58)
NTD Z 15,841e25,000 1937 (30.18) 1869 (30.33) 68 (26.56)
NTD >25,000 635 (9.89) 620 (10.06) 15 (5.86)
Hospital type <0.0001
Medical center 1409 (21.95) 1243 (20.17) 166 (64.84)
Local hospital 5009 (78.05) 4919 (79.83) 90 (35.16)
Elapsed time (mo)a 38.12  34.1
Data are presented as n (%).
*A p value was based on the Chi-square test.
NTD: New Taiwan Dollars.
a Elapsed time is the time from diagnosis of diabetic CLI to surgical revascularization.
Table 2 Demographic characteristics and comorbid
medical disorders of diabetic patients in Taiwan with crit-
ical limb ischemia, stratified by amputation or no
amputation.
Patients’
characteristics
Amputation
369 (5.75)
No amputation
6049 (94.25)
p*
Age (y)
<50 36 (9.76) 1087 (17.97) <0.0001
50e59 66 (17.89) 1225 (20.25)
60e69 109 (29.54) 1621 (26.80)
 70 158 (42.82) 2116 (34.98)
Gender
Male 221 (59.89) 3023 (49.98) 0.0002
Female 148 (42.11) 3026 (50.02)
Comorbid disorders
Cardiovascular 95 (25.75) 470 (7.77) <0.0001
Neurologic 73 (19.78) 826 (13.66) 0.0010
Pulmonary 37 (10.03) 670 (11.08) 0.5320
Renal 59 (15.99) 329 (5.44) <0.0001
Hepatic &
gastrointestinal
53 (14.36) 1148 (18.98) 0.0273
Rheumatologic 1 (0.27) 51 (0.84) 0.3679
Data are presented as n (%).
*A p value was based on the Chi-square test or the Fisher’s exact
test, as appropriate.
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CI, 1.681-2.409) and cardiovascular disease posed a hazard
of a 1.823-fold (95% CI Z 1.560e2.130) increase in mor-
tality, compared to diabetic patients with CLI but without
renal disease. Concurrent neurological, pulmonary, and
gastrointestinal-hepatic diseases also increased the hazard
of mortality for diabetic CLI patients.
4. Discussion
Our study analyzed longitudinal follow-up claim data on
6418 diabetic patients with CLI in Taiwan. Our results
demonstrated that diabetic CLI patients who needed
revascularization surgeries had more major comorbidities,
a higher amputation rate, and a higher mortality rate.
The major strength of our study is that we used a nation-
wide population-based database that included a relatively
large number of patients with diabetes that was complicated
by CLI. The longitudinal follow-up data permitted a clear and
temporal observation of the epidemiological profiles and the
association between treatment modalities and the end out-
comes (e.g., limb amputation and mortality rates). Further-
more, we used the procedure codes and the order codes to
confirm the correctness of our identified patients; therefore,
the chances of misclassification were low.
In this study,we found that the incidence of CLI in diabetic
patients rose graduallywith aging. This findingwas consistent
Table 3 Subclassifications of the 6418 diabetic CLI patients, based on the treatment modality and the outcome of amputation
after medical or revascularization treatment.
Group Conservative treatment Revascularization (n Z 256 cases; 346 procedures)
Angioplasty Endarterectomy Bypass Combination pa,*
Patientsa 6162 47 (18.36) 51 (19.92) 132 (51.56) 26 (10.02) <0.001
Proceduresa 0 60 (17.34) 61 (17.63) 157 (45.38) 68 (19.65) <0.001
Age 63.27  13.65 68.07  13.04 71.74  9.01 61.37  11.93 63.72  11.95 <0.001
Gender 0.228
Maleb 3092 (50.18) 29 (56.86) 31 (67.39) 81 (61.36) 11 (42.31)
Femaleb 3072 (49.85) 22 (53.14) 16 (32.61) 51 (38.64) 15 (57.69)
Amputation 328 (5.32) 41 (16.08)
6 (12.77) 11 (21.57) 14 (10.61) 10 (38.46) 0.003
AKc 45 (0.73) 1 (2.13) 3 (5.88) 1 (0.76) 1 (3.85)
BKd 110 (1.79) 3 (6.38) 7 (13.73) 5 (3.79) 6 (23.08)
Foot or toe 173 (2.81) 2 (4.26) 1 (1.96) 8 (6.06) 3 (11.54)
Data are presented as n (%) or mean  SD.
AK Z above-knee amputation; BK Z below-knee amputation.
*A p value compared the in-between revascularization group by using analysis of variance, the Chi-square test, or Fisher’s exact test, as
appropriate.
a Percentage of specific intervention in revascularization cohort.
b Percentage between Male/Female.
c AK (above-knee amputation) includes disarticulation of the knee and hip.
d BK (below-knee amputation) includes disarticulation of the ankle and toe.
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between old age and CLI in Caucasians and in Hispanics.22,23
Old age and diabetes mellitus may predispose patients to
distal atherosclerotic disease.8,24 However, we did not find a
significant gender discrepancy in CLI in diabetic patients in
Taiwan. This was different from results in other studies in the
medical literature that report thatmenwith diabetes are at a
higher risk for CLI.24 In the Framingham study,25 the age-
adjusted incidence of limb ischemia was 50% greater in men
with diabetes than in women with diabetes. However, as
indicated in the present study, a recent survey by a teachingTable 4 Crude and adjusted hazard ratios for amputation in th
Characteristics Crude hazard ratio (9
Age (y)
<50 1.000
50e59 1.660 (1.092e2.522)*
60e69 2.097 (1.423e3.088)*
 70 2.487 (1.712e3.611)*
Gender
Male 1.000
Female 0.712 (0.576e0.881)*
Comorbid disorders
Cardiovascular 4.126 (3.230e5.272)*
Neurologic 1.593 (1.218e2.083)*
Pulmonary 0.967 (0.682e1.371)
Renal 3.484 (2.611e4.649)*
Hepatic and
gastrointestinal
0.768 (0.570e1.033)
Rheumatologic 0.340 (0.048e2.412)
CI Z confidence interval.
*p < 0.05.hospital in Taiwan also reported no significant gender differ-
ence in the prevalence of diabetic peripheral artery
obstructive disease.8 We suspected that racial or ethnic dif-
ferences may contribute to such different results. In the
present study, a significant gender discrepancy was never-
theless noted in patients who needed revascularization
intervention. Chen et al26 in their most recent reportdwhich
used 14,241 patients with peripheral artery disease from a
1997e2004 longitudinal database in Taiwandsimilarly
demonstrated that significantly more males received revas-
cularization therapy than females.e 6418 diabetic patients with critical limb ischemia.
5% CI) Adjusted hazard ratio (95% CI)
1.000
1.683 (1.107e2.559)*
1.962 (1.328e2.900)*
2.142 (1.462e3.137)*
1.000
0.711 (0.574e0.881)*
3.472 (2.691e4.480)*
1.299 (0.988e1.708)
0.677 (0.473e0.969)*
2.801 (2.084e3.764)*
0.696 (0.516e0.938)*
0.385 (0.054e2.745)
Table 5 Demographics of the 6418 diabetic critical limb
ischemia patients, stratified by mortality or survival.
Patients’
characteristics
Mortality Survival p*
1195 (18.62) 5223 (81.38)
Age (y) <0.0001
<50 79 (6.61) 1044 (19.99)
50e59 132 (11.05) 1159 (22.19)
60e69 276 (23.10) 1454 (27.84)
 70 708 (59.25) 1566 (29.98)
Gender 0.0017
Male 653 (54.64) 2591 (49.61)
Female 542 (45.36) 2632 (50.39)
Comorbid disorders
Cardiovascular 201 (16.82) 364 (6.97) <0.0001
Neurologic 281 (23.51) 618 (11.83) <0.0001
Pulmonary 207 (17.32) 500 (9.57) <0.0001
Renal 140 (11.72) 248 (4.75) <0.0001
Hepatic and
gastrointestinal
269 (22.51) 932 (17.84) 0.0002
Rheumatologic 10 (0.84) 42 (0.80) 0.9095
Data are presented as n (%).
*p, based on the Chi-square test.
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tation and mortality rates for diabetes patients with CLI in
Taiwan were not as high as the rates reported by LoGerfo
et al in the United States27 and Faglia et al in Italy.28 Direct
comparisons of the incidence of amputation or mortality
between different studies usually are difficult because of
diverse study designs, different patient demographics,
hospital levels, and follow-up periods. Our patients in the
present study came from the general population; whereas
patients in the study by Faglia et al28 were referred from
foot centers; therefore, the revascularization rate of theTable 6 Crude and adjusted hazard ratios for mortality in the
Patients’ characteristics Crude hazard ratio
Age (y)
<50 1.000
50e59 1.510 (1.141e1.998
60e69 2.430 (1.892e3.121
 70 5.457 (4.324e6.886
Gender
Male 1.000
Female 0.834 (0.744e0.935
Comorbid disorders
Cardiovascular 2.505 (2.152e2.915
Neurologic 2.246 (1.962e2.570
Pulmonary 1.902 (1.637e2.209
Renal 2.511 (2.104e2.997
Hepatic &
gastrointestinal
1.345 (1.174e1.542
Rheumatologic 1.004 (0.539e1.871
CI Z confidence interval.
*p < 0.05.latter study was very high. Similarly low-incidence reports
were previously reported in two Taiwanese population-
based studies26,29 and in some eastern Asian ethnic
groups.30e32 Chen et al report crude rates of 9.4% for limb
amputation and 5.9% for peripheral revascularization in
patients with peripheral artery disease.26 More than 60% of
their study cases had comorbid diabetes mellitus. Another
paper by Chen et al reports an overall amputation rate of
1.89% and revascularization rate of 0.52% in Taiwanese
patients with general diabetes.29 We reported a crude
amputation rate of 5.75% and revascularization rate of
3.99% during our follow-up period, which lasted until 2009.
However, our study target patients were not exactly the
same as the patients in the Chen study because we focused
mainly on diabetic patients with CLI.
In addition to the racial and ethnic differences, another
possible explanation for the low incidence rate of revas-
cularization may be that since 2001 Taiwan’s NHI system
has implemented a pay-for-performance program for dia-
betes, which provides financial incentives for cost-saving
treatment and patient education to prevent poor out-
comes. The implementing of such a program in The
Netherlands has successfully reduced the incidence of
amputation and the need for revascularization.33
Our present study also demonstrated that patients who
needed surgical revascularization interventions had more
comorbid disorders (such as cardiovascular and renal dis-
eases) than patients who needed only conservative treat-
ment. This may explain the higher limb amputation and
mortality rates in diabetic patients with CLI who needed
surgical interventions in comparison to the conservative
treatment cohort. This was another main finding of our
observation. This result was consistent with previous
studies that report higher risk factors for limb loss in pa-
tients with CLI who had concurrent diseases such as dia-
betes, advanced heart disease, and severe renal failure
that reduce blood flow to the microvascular bed.24,34
Revascularization apparently does not rescue these6418 diabetic critical limb ischemia patients.
(95% CI) Adjusted hazard ratio (95% CI)
1.000
) 1.468 (1.109e1.943)*
)* 2.190 (1.703e2.817)*
)* 4.501 (3.553e5.701)*
1.000
)* 0.866 (0.772e0.972)*
)* 1.823 (1.560e2.130)*
)* 1.590 (1.387e1.822)*
)* 1.256 (1.076e1.466)*
)* 2.013 (1.681e2.409)*
)* 1.184 (1.032e1.357)*
) 0.957 (0.513e1.787)
Amputation and mortality rates of diabetics with CLI 85patients from poor outcomes, especially when the disease
is far advanced. It is possible that the patients decide to
have surgical treatment at a relatively late stage of disease
progression. Therefore, these two cohorts represent early
and late presenters in diabetic patients with critical lower
limb ischemia. Differences in disease severity and comor-
bidity would play a key role in the poor outcome in the
surgical group. Another possible explanation is that the
patients undergoing revascularization procedures are at a
significantly high risk for peri-procedural cardiac morbidity
and mortality. Based on one retrospective study from a
hospital in Taiwan, the mortality in diabetic patients after
lower extremity amputations is reportedly high.35 Within a
10-year period, 39.01% (34/87) of diabetic amputees died.
Cerebral infarction, infection, and diabetes mellitus were
the most commonly reported causes of death.
Doctors and patients usually decide on treatment mo-
dalities, especially for invasive procedures.36 The decision
may also sometimes be influenced by hospital facilities or by
economic reasons.37,38 In our study, the mean elapsed time
from the diagnosis of CLI to receiving revascularization
[presented as the mean  the standard deviation (SD)] was
38.12  34.10 months. This suggests that the patients had a
period of conservative treatment prior to deciding to have
surgical intervention. We also found that approximately 65%
of revascularization procedures in Taiwan were performed
at medical centers. This may be because most local hospi-
tals in Taiwan have no cardiovascular or plastic surgery
specialties; therefore, patients judged as needing surgical
intervention were transferred to medical centers.
There are several limitations to the present study, just as
there are limitations in retrospective studies using a national
health database such as theTaiwanNHIRDor the databases of
American insurance companies. First, a selection bias may
exist becausephysiciansor hospital facilitiesmostly influence
the treatment modality. Therefore, we did not compare the
outcomes between patients receiving different treatments.
We instead emphasized epidemiological descriptions. Sec-
ond, only the medical history of the sampled patients from
theyear 1996and thereafter couldbe traced.Wecouldnotbe
certain if our patients had revascularization surgeries prior to
January 1996. This may have influenced our findings. Third,
certain important characteristics such as the body mass
index, alcohol drinking, and tobacco smoking habits were not
available in the claim database of the Taiwan National Health
Research Institute. Therefore, we could not adjust for these
variables as contributing factors in this study. Fourth, our
study population is mainly Chinese; therefore, all our results
may not apply directly to other racial or ethnic groups.
In conclusion, diabetic patients judged as needing sur-
gical revascularization or conservative treatment for CLI
had different comorbid profiles. This may explain the
higher overall amputation rate in patients who needed
revascularization. The other common risk factors for
amputation and mortality are an age >50 years and con-
current cardiovascular or renal diseases.Disclosure of funding
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